Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation - Schedule of Stock Option Activity (Details)

v3.21.1
Stock-Based Compensation - Schedule of Stock Option Activity (Details)
 12 Months Ended
Dec. 31, 2020
USD ($)
$ / shares
shares
Share-based Payment Arrangement [Abstract]  
Shares outstanding beginning balance | shares 415,678
Shares granted | shares 525,550
Shares exercised | shares
Shares forfeited or expired | shares (92,409)
Shares outstanding ending balance | shares 848,819
Shares exercisable ending balance | shares 361,501
Shares vested and expected to vest | shares 659,465
Weighted average grant price outstanding beginning balance | $ / shares $ 12.50
Weighted average grant price granted | $ / shares 6.24
Weighted average grant price exercised | $ / shares
Weighted average grant price forfeited or expired | $ / shares 11.18
Weighted average grant price outstanding ending balance | $ / shares 8.76
Weighted average grant price exercisable ending balance | $ / shares 11.81
Weighted average grant price vested and expected to vest | $ / shares $ 9.48
Weighted average remaining contractual period outstanding beginning balance 8 years 5 months 12 days
Weighted average remaining contractual period granted 9 years 4 months 20 days
Weighted average remaining contractual period outstanding ending balance 8 years 7 months 2 days
Weighted average remaining contractual period exercisable ending balance 7 years 9 months 7 days
Weighted average remaining contractual period vested and expected to vest 8 years 4 months 20 days
Aggregate intrinsic value outstanding beginning balance | $
Aggregate intrinsic value granted | $
Aggregate intrinsic value exercised | $
Aggregate intrinsic value forfeited or expired | $
Aggregate intrinsic value outstanding ending balance | $
Aggregate intrinsic value exercisable ending balance | $
Aggregate intrinsic value vested and expected to vest | $